These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 20590092)

  • 21. Carbonic anhydrase inhibitors. Interaction of 2-(hydrazinocarbonyl)-3-phenyl-1H-indole-5-sulfonamide with 12 mammalian isoforms: kinetic and X-ray crystallographic studies.
    Güzel O; Temperini C; Innocenti A; Scozzafava A; Salman A; Supuran CT
    Bioorg Med Chem Lett; 2008 Jan; 18(1):152-8. PubMed ID: 18024029
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Carbonic anhydrase inhibitors. Interaction of indapamide and related diuretics with 12 mammalian isozymes and X-ray crystallographic studies for the indapamide-isozyme II adduct.
    Temperini C; Cecchi A; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2008 Apr; 18(8):2567-73. PubMed ID: 18374572
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carbonic anhydrase inhibitors: clash with Ala65 as a means for designing inhibitors with low affinity for the ubiquitous isozyme II, exemplified by the crystal structure of the topiramate sulfamide analogue.
    Winum JY; Temperini C; El Cheikh K; Innocenti A; Vullo D; Ciattini S; Montero JL; Scozzafava A; Supuran CT
    J Med Chem; 2006 Nov; 49(24):7024-31. PubMed ID: 17125255
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carbonic anhydrase inhibitors: the X-ray crystal structure of ethoxzolamide complexed to human isoform II reveals the importance of thr200 and gln92 for obtaining tight-binding inhibitors.
    Di Fiore A; Pedone C; Antel J; Waldeck H; Witte A; Wurl M; Scozzafava A; Supuran CT; De Simone G
    Bioorg Med Chem Lett; 2008 Apr; 18(8):2669-74. PubMed ID: 18359629
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Carbonic anhydrase inhibitors. X-ray crystal studies of the carbonic anhydrase II-trithiocarbonate adduct--an inhibitor mimicking the sulfonamide and urea binding to the enzyme.
    Temperini C; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2010 Jan; 20(2):474-8. PubMed ID: 20005709
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sulfonamide linked neoglycoconjugates--a new class of inhibitors for cancer-associated carbonic anhydrases.
    Lopez M; Bornaghi LF; Innocenti A; Vullo D; Charman SA; Supuran CT; Poulsen SA
    J Med Chem; 2010 Apr; 53(7):2913-26. PubMed ID: 20201556
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Carbonic anhydrase inhibitors: inhibition of cytosolic/tumor-associated isoforms I, II, and IX with iminodiacetic carboxylates/hydroxamates also incorporating benzenesulfonamide moieties.
    Santos MA; Marques S; Vullo D; Innocenti A; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2007 Mar; 17(6):1538-43. PubMed ID: 17251018
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exploiting the hydrophobic and hydrophilic binding sites for designing carbonic anhydrase inhibitors.
    De Simone G; Alterio V; Supuran CT
    Expert Opin Drug Discov; 2013 Jul; 8(7):793-810. PubMed ID: 23627619
    [TBL] [Abstract][Full Text] [Related]  

  • 29. S-glycosyl primary sulfonamides--a new structural class for selective inhibition of cancer-associated carbonic anhydrases.
    Lopez M; Paul B; Hofmann A; Morizzi J; Wu QK; Charman SA; Innocenti A; Vullo D; Supuran CT; Poulsen SA
    J Med Chem; 2009 Oct; 52(20):6421-32. PubMed ID: 19827837
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recent advances in the discovery of zinc-binding motifs for the development of carbonic anhydrase inhibitors.
    Winum JY; Supuran CT
    J Enzyme Inhib Med Chem; 2015 Apr; 30(2):321-4. PubMed ID: 24939097
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nanoscale enzyme inhibitors: fullerenes inhibit carbonic anhydrase by occluding the active site entrance.
    Innocenti A; Durdagi S; Doostdar N; Strom TA; Barron AR; Supuran CT
    Bioorg Med Chem; 2010 Apr; 18(8):2822-8. PubMed ID: 20363143
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Carbonic anhydrase inhibitors. Synthesis of water-soluble, topically effective, intraocular pressure-lowering aromatic/heterocyclic sulfonamides containing cationic or anionic moieties: is the tail more important than the ring?
    Scozzafava A; Menabuoni L; Mincione F; Briganti F; Mincione G; Supuran CT
    J Med Chem; 1999 Jul; 42(14):2641-50. PubMed ID: 10411484
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Carbonic anhydrase activators: X-ray crystal structure of the adduct of human isozyme II with L-histidine as a platform for the design of stronger activators.
    Temperini C; Scozzafava A; Puccetti L; Supuran CT
    Bioorg Med Chem Lett; 2005 Dec; 15(23):5136-41. PubMed ID: 16214338
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Carbonic anhydrase inhibitors: inhibition of human cytosolic isozymes I and II and tumor-associated isozymes IX and XII with S-substituted 4-chloro-2-mercapto-5-methyl-benzenesulfonamides.
    Saczewski F; Innocenti A; Sławiński J; Kornicka A; Brzozowski Z; Pomarnacka E; Scozzafava A; Temperini C; Supuran CT
    Bioorg Med Chem; 2008 Apr; 16(7):3933-40. PubMed ID: 18242998
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Crystal structure of the complex between human carbonic anhydrase II and the aromatic inhibitor 1,2,4-triazole.
    Mangani S; Liljas A
    J Mol Biol; 1993 Jul; 232(1):9-14. PubMed ID: 8331673
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Carbonic anhydrase inhibitors: X-ray crystallographic studies for the binding of 5-amino-1,3,4-thiadiazole-2-sulfonamide and 5-(4-amino-3-chloro-5-fluorophenylsulfonamido)-1,3,4-thiadiazole-2-sulfonamide to human isoform II.
    Menchise V; De Simone G; Di Fiore A; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2006 Dec; 16(24):6204-8. PubMed ID: 17000110
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reconsidering anion inhibitors in the general context of drug design studies of modulators of activity of the classical enzyme carbonic anhydrase.
    Nocentini A; Angeli A; Carta F; Winum JY; Zalubovskis R; Carradori S; Capasso C; Donald WA; Supuran CT
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):561-580. PubMed ID: 33615947
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Carbonic anhydrase inhibitors drug design.
    McKenna R; Supuran CT
    Subcell Biochem; 2014; 75():291-323. PubMed ID: 24146385
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Carbonic anhydrase inhibitors. Interaction of 2-N,N-dimethylamino-1,3,4-thiadiazole-5-methanesulfonamide with 12 mammalian isoforms: kinetic and X-ray crystallographic studies.
    Temperini C; Cecchi A; Boyle NA; Scozzafava A; Cabeza JE; Wentworth P; Blackburn GM; Supuran CT
    Bioorg Med Chem Lett; 2008 Feb; 18(3):999-1005. PubMed ID: 18162396
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Carbonic anhydrase inhibitors. Inhibition of the zinc and cobalt gamma-class enzyme from the archaeon Methanosarcina thermophila with anions.
    Innocenti A; Zimmerman S; Ferry JG; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2004 Jun; 14(12):3327-31. PubMed ID: 15149700
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.